Novel RIPK1 Inhibitors for Treating Neurodegenerative, Autoimmune, and Inflammatory Diseases.
作者信息
Sabnis Ram W
机构信息
Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia30309, United States.
出版信息
ACS Med Chem Lett. 2022 Mar 2;13(4):524-525. doi: 10.1021/acsmedchemlett.2c00059. eCollection 2022 Apr 14.
Abstract
摘要
相似文献
1
Novel RIPK1 Inhibitors for Treating Neurodegenerative, Autoimmune, and Inflammatory Diseases.用于治疗神经退行性、自身免疫性和炎性疾病的新型RIPK1抑制剂。
ACS Med Chem Lett. 2022 Mar 2;13(4):524-525. doi: 10.1021/acsmedchemlett.2c00059. eCollection 2022 Apr 14.
2
Novel Fused Triazole Compounds as RIPK1 Inhibitors for Treating Neurodegenerative, Autoimmune, and Inflammatory Diseases.新型稠合三唑化合物作为用于治疗神经退行性、自身免疫性和炎症性疾病的RIPK1抑制剂
ACS Med Chem Lett. 2024 Jan 26;15(2):177-178. doi: 10.1021/acsmedchemlett.4c00011. eCollection 2024 Feb 8.
3
Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target.受体相互作用蛋白激酶 1（RIPK1）作为治疗靶点。
Nat Rev Drug Discov. 2020 Aug;19(8):553-571. doi: 10.1038/s41573-020-0071-y. Epub 2020 Jul 15.
4
Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis.发现针对 RIPK1 激酶活性的强效坏死性凋亡抑制剂，用于治疗炎症性疾病和癌症转移。
Cell Death Dis. 2019 Jun 24;10(7):493. doi: 10.1038/s41419-019-1735-6.
5
Novel insights into RIPK1 as a promising target for future Alzheimer's disease treatment.对RIPK1作为未来阿尔茨海默病治疗的一个有前景靶点的新见解。
Pharmacol Ther. 2022 Mar;231:107979. doi: 10.1016/j.pharmthera.2021.107979. Epub 2021 Sep 2.
6
Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activity.设计、合成和评估具有体内抗炎活性的强效 RIPK1 抑制剂。
Eur J Med Chem. 2022 Jan 15;228:114036. doi: 10.1016/j.ejmech.2021.114036. Epub 2021 Dec 8.
7
Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I/Ib studies in healthy subjects and patients.用于神经退行性疾病的新型 RIPK1 抑制剂 SAR443060（DNL747）的安全性、药代动力学和靶标占有率：在健康受试者和患者中进行的随机、安慰剂对照、双盲 I/ Ib 期研究。
Clin Transl Sci. 2022 Aug;15(8):2010-2023. doi: 10.1111/cts.13317. Epub 2022 Jun 1.
8
Microglial Dysfunction in Neurodegenerative Diseases via RIPK1 and ROS.通过RIPK1和ROS介导的神经退行性疾病中的小胶质细胞功能障碍
Antioxidants (Basel). 2022 Nov 7;11(11):2201. doi: 10.3390/antiox11112201.
9
Targeting RIPK1 kinase for modulating inflammation in human diseases.靶向 RIPK1 激酶调节人类疾病中的炎症反应。
Front Immunol. 2023 Mar 8;14:1159743. doi: 10.3389/fimmu.2023.1159743. eCollection 2023.
10
Harnessing Protein-Ligand Interaction Fingerprints to Predict New Scaffolds of RIPK1 Inhibitors.利用蛋白-配体相互作用指纹预测 RIPK1 抑制剂的新骨架。
Molecules. 2022 Jul 23;27(15):4718. doi: 10.3390/molecules27154718.
引用本文的文献
1
The deubiquitinating protein OTUD6B promotes lung adenocarcinoma progression by stabilizing RIPK1.去泛素化蛋白 OTUD6B 通过稳定 RIPK1 促进肺腺癌进展。
Biol Direct. 2024 Jun 16;19(1):46. doi: 10.1186/s13062-024-00489-8.
2
Novel Fused Triazole Compounds as RIPK1 Inhibitors for Treating Neurodegenerative, Autoimmune, and Inflammatory Diseases.新型稠合三唑化合物作为用于治疗神经退行性、自身免疫性和炎症性疾病的RIPK1抑制剂
ACS Med Chem Lett. 2024 Jan 26;15(2):177-178. doi: 10.1021/acsmedchemlett.4c00011. eCollection 2024 Feb 8.
本文引用的文献
1
The role of necroptosis in disease and treatment.坏死性凋亡在疾病与治疗中的作用。
MedComm (2020). 2021 Dec 20;2(4):730-755. doi: 10.1002/mco2.108. eCollection 2021 Dec.
2
Novel insights into RIPK1 as a promising target for future Alzheimer's disease treatment.对RIPK1作为未来阿尔茨海默病治疗的一个有前景靶点的新见解。
Pharmacol Ther. 2022 Mar;231:107979. doi: 10.1016/j.pharmthera.2021.107979. Epub 2021 Sep 2.
3
The latest information on the RIPK1 post-translational modifications and functions.RIPK1 翻译后修饰及功能的最新信息。
Biomed Pharmacother. 2021 Oct;142:112082. doi: 10.1016/j.biopha.2021.112082. Epub 2021 Aug 24.
4
25 years of research put RIPK1 in the clinic.25 年的研究将 RIPK1 推向临床。
Semin Cell Dev Biol. 2021 Jan;109:86-95. doi: 10.1016/j.semcdb.2020.08.007. Epub 2020 Sep 13.
5
RIPK1: A rising star in inflammatory and neoplastic skin diseases.RIPK1：炎症性和肿瘤性皮肤病领域的一颗冉冉升起的新星。
J Dermatol Sci. 2020 Sep;99(3):146-151. doi: 10.1016/j.jdermsci.2020.06.001. Epub 2020 Jun 11.
6
Inhibitors Targeting RIPK1/RIPK3: Old and New Drugs.靶向 RIPK1/RIPK3 的抑制剂：旧药与新药。
Trends Pharmacol Sci. 2020 Mar;41(3):209-224. doi: 10.1016/j.tips.2020.01.002. Epub 2020 Feb 5.
Zotero 插件